Seeking expertise on addiction medicine...

Heather Leslie heather.leslie at
Thu Feb 18 22:45:43 EST 2016

Thanks for the offer Marcus,

The real tricky one at present is tobacco and I hope that when we get that clearer, the patterns will apply with alcohol and other drugs. Will be in touch.

Can you and anyone else who is interested please adopt the archetypes in CKM so we can make sure you get included in the reviews when they commence.


From: openEHR-clinical [mailto:openehr-clinical-bounces at] On Behalf Of Marcus Baw
Sent: Friday, 19 February 2016 10:04 AM
To: For openEHR clinical discussions <openehr-clinical at>
Subject: Re: Seeking expertise on addiction medicine...

Hi Heather,
I have a couple of years' experience dealing with and prescribing for substance misuse in a British prison environment. The main drugs in question were opioids, cocaine, amphetamines, benzodiazepines, alcohol, and commonly abused prescription drugs such as pregabalin and gabapentin.
I'm not sure if this stuff is helpful from a 'modelling' point of view but I'm happy to help out if it's in any way useful.

On 18 February 2016 at 06:55, Rikard Lövström <rikard.lovstrom at<mailto:rikard.lovstrom at>> wrote:

Hi Heather,

I did a Powerpoint presentation in 2011 looken at 30 key figures from quality registers on tobacco use, compared it to the 10 put forward by an expert group and finally concluded on the two (!) I thought was sufficient.

I can try to find it. By the weekend.

Kind regards,

Rikard Lövström
Den 18 feb 2016 07:50 skrev "Heather Leslie" <heather.leslie at<mailto:heather.leslie at>>:
Hi everyone,

The CKM Editorial teams in Norway and the international openEHR CKM are seeking expertise for development of our tobacco, drug and alcohol archetypes – all of which follow a similar pattern around addition and its management.

The tobacco archetype in particular is causing some difficulty in cracking the best pattern – the multitude of ways that this data is represented in current systems is compounded by the multitude of different forms of tobacco use (non-smoking and smoking) and forms of tobacco used in smoking… There has been a lot of discussion and various iterations over the past few years – it is now time to try to pin it down and publish.

We think that consultation with an expert or two in this area will help us establish the best approach for a robust candidate archetype, which will then go out to the community for further review and collaboration.

If you’d like to volunteer your services, please let me know.

If you can refer me to someone else who could assist, please do so.

Many thanks in anticipation,


Informatics Lead, Ocean Informatics<>
Clinical Programme Lead, openEHR Foundation<>
p: +61 418 966 670<tel:%2B61%20418%20966%20670>   skype: heatherleslie   twitter: @omowizard

openEHR-clinical mailing list
openEHR-clinical at<mailto:openEHR-clinical at>

openEHR-clinical mailing list
openEHR-clinical at<mailto:openEHR-clinical at>

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <>

More information about the openEHR-clinical mailing list